Search hospitals
>
Ontario
>
TORONTO
Sunnybrook Research Institute
Claim this profile
TORONTO, Ontario M4N 3M5
Global Leader in Parkinson's disease
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
92 reported clinical trials
14 medical researchers
Summary
Sunnybrook Research Institute is a medical facility located in TORONTO, Ontario. This center is recognized for care of Parkinson's disease, Breast Cancer, Prostate Cancer, Cancer, Pancreatic Cancer and other specialties. Sunnybrook Research Institute is involved with conducting 92 clinical trials across 146 conditions. There are 14 research doctors associated with this hospital, such as Sandra Black, MD, Laurence Klotz, MD, Nir Lipsman, MD, and Andrew Loblaw, MD.
Area of expertise
Parkinson's Disease
Sunnybrook Research Institute has run 25 trials for Parkinson's disease. Some of their research focus areas include:
Breast Cancer
Sunnybrook Research Institute has run 19 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Sandra Black, MD
Sunnybrook Health Sciences Centre
6 years of reported clinical research
Laurence Klotz, MD
Sunnybrook Health Sciences Centre
7 years of reported clinical research
Nir Lipsman, MD
Sunnybrook Research Institute
6 years of reported clinical research
Andrew Loblaw, MD
Sunnybrook Health Sciences Centre
7 years of reported clinical research
Clinical Trials running at Sunnybrook Research Institute
Prostate Cancer
Ovarian Cancer
Lung Cancer
Brain Tumor
Breast Cancer
Pancreatic Cancer
Cancer
Endometrial Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Enzalutamide + Standard Therapy
for Prostate Cancer
This trial is testing if adding enzalutamide, a pill that blocks male hormones, to standard radiation and hormone treatments can improve the quality of life for prostate cancer patients. Participants will receive treatments and be monitored over several months and years to see how they do. Enzalutamide is an antiandrogen used to treat both metastatic and nonmetastatic prostate cancer.
Recruiting
2 awards
Phase 2
9 criteria
Opevesostat + Hormone Therapy
for Prostate Cancer
This trial is testing a new drug called opevesostat for advanced prostate cancer patients who don't respond to usual care. The drug aims to stop the cancer from growing and spreading, potentially helping patients live longer.
Recruiting
2 awards
Phase 3
10 criteria
BMS-986365
for Prostate Cancer
The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate Cancer.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sunnybrook Research Institute?
Sunnybrook Research Institute is a medical facility located in TORONTO, Ontario. This center is recognized for care of Parkinson's disease, Breast Cancer, Prostate Cancer, Cancer, Pancreatic Cancer and other specialties. Sunnybrook Research Institute is involved with conducting 92 clinical trials across 146 conditions. There are 14 research doctors associated with this hospital, such as Sandra Black, MD, Laurence Klotz, MD, Nir Lipsman, MD, and Andrew Loblaw, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.